Rahul Gupta, MD, speaking at the 2023 National Advocacy Conference
·
5 Min Read

Every 5 minutes a person dies of drug overdose. This must end.

Rahul Gupta, MD, MPH, is the first physician to direct the White House’s drug-control policy. Learn why he says treatment is key to the strategy.

Behavioral Health
·
2 Min Read

AMA statement on making naloxone available over the counter

The AMA strongly supports the FDA decision to make the opioid overdose-reversing drug naloxone available over the counter, a position we have long championed.

Press Releases
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of March 6, 2023

In the news: Fatal opioid poisonings in children, lingering gastrointestinal problems after COVID infection, treatment for statin-intolerant patients and more.

Publications & Newsletters
·
2 Min Read

AMA: FDA panels’ naloxone recommendation will save lives

Two advisory committees voted today to recommend to the FDA that naloxone, the overdose-reversing drug, be available over the counter.

Press Releases
·
2 Min Read

AMA honors Director of National Drug Control Policy with award

Dr. Gupta is the first physician to serve as Director of National Drug Control Policy and lead the White House Office of National Drug Control Policy (ONDCP).

Press Releases
Profile of smiling person looking out the window
·
4 Min Read

Meet 25 heroes saving lives amid the drug-overdose epidemic

It’s time to pursue policies shown to help. An AMA report celebrates the physicians and advocates working to follow the evidence.

Behavioral Health
·
8 Min Read

Dec. 2, 2022: National Advocacy Update

Moving from policy to action: Fighting the nation’s drug overdose and death epidemic, and more in the latest National Advocacy Update.

Advocacy Update
Bruce Scott, MD, and Lisa Egbert, MD, HOD speakers at 2022 Interim
·
10 Min Read

ICYMI: 10 stories to read from the 2022 AMA Interim Meeting

The AMA House of Delegates leads the charge to protect reproductive health care, stop climate change, end the overdose epidemic, and prevent gun violence.

Interim Meeting
Delegates stand in line to speak at the 2022 Interim Meeting
·
3 Min Read

Harm-reduction efforts needed to curb overdose epidemic

AMA backs greater use of point-of-care fentanyl test strips and using opioid-litigation settlement funds to boost physician training. Learn more.

Behavioral Health